What outcome after pleurodesis in malignant pleural effusion in lung cancer?

Hanene Smadhi (Ariana, Tunisia), Hanen Smadhi, Aymen Ayari, Hela Kammoun, Islam Mejri, Hazem Zribi, Dorra Greb, Ines Akrout, Hela Hassan, Hajer Abdelghaffar, Leila Fekih, MLamine Megdiche

Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session: Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Session type: Thematic Poster Session
Number: 4335
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hanene Smadhi (Ariana, Tunisia), Hanen Smadhi, Aymen Ayari, Hela Kammoun, Islam Mejri, Hazem Zribi, Dorra Greb, Ines Akrout, Hela Hassan, Hajer Abdelghaffar, Leila Fekih, MLamine Megdiche. What outcome after pleurodesis in malignant pleural effusion in lung cancer?. Eur Respir J 2015; 46: Suppl. 59, 4335

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014



Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Risk of occult pleural infection in patients with malignant effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013